These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1625312)

  • 41. Serotype, hemolysin production, and adherence characteristics of strains of Escherichia coli causing urinary tract infection in dogs.
    Senior DF; deMan P; Svanborg C
    Am J Vet Res; 1992 Apr; 53(4):494-8. PubMed ID: 1350184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Septicemia-inducing Escherichia coli O115:K"V165"F165(1) resists killing by porcine polymorphonuclear leukocytes in vitro: role of F165(1) fimbriae and K"V165" O-antigen capsule.
    Ngeleka M; Martineau-Doizé B; Fairbrother JM
    Infect Immun; 1994 Feb; 62(2):398-404. PubMed ID: 7507891
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Role of nonenterotoxigenic Escherichia coli strains (K99-,ST-) in the neonatal pathology of the calf].
    De Rycke J
    Ann Rech Vet; 1984; 15(1):75-95. PubMed ID: 6385807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro cytotoxic effect of alpha-hemolytic Escherichia coli on human blood granulocytes. Correlation with size of alpha-hemolysin production.
    Gadeberg OV; Larsen SO
    APMIS; 1988 Apr; 96(4):337-41. PubMed ID: 2897205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mannose-resistant hemagglutination (MRHA), type 1 fimbriae and hemolysin production of urinary and fecal Escherichia coli strains].
    Karabiber N; Türet S
    Mikrobiyol Bul; 1992 Jan; 26(1):12-6. PubMed ID: 1349420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of Escherichia coli haemolysin in the pathogenic synergy of colonic bacteria in subcutaneous abscess formation in mice.
    Ushijima T; Takahashi M; Seto A
    J Med Microbiol; 1990 Sep; 33(1):17-22. PubMed ID: 2146395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Some biological properties of urinary and faecal E. coli isolated from cases of urinary infection.
    Chugh TD; Garg ML; Prakash C; Malik AK
    Indian J Med Res; 1978 Sep; 68():418-22. PubMed ID: 369997
    [No Abstract]   [Full Text] [Related]  

  • 48. Halothane reversibly inhibits human neutrophil bacterial killing.
    Welch WD
    Anesthesiology; 1981 Dec; 55(6):650-4. PubMed ID: 7030150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cefdinir-induced modification of the susceptibility of bacteria to the antibacterial activity of human serum and polymorphonuclear neutrophils.
    Pruul H; McDonald PJ
    Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):170-6. PubMed ID: 8508815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced hemoglobin as an inhibitor of human polymorphonuclear leukocyte bacterial killing. Role of hemoglobin--oxygen tension in polymorphonuclear function.
    Welch WD; Rose DM; Carlson R
    Surgery; 1982 Jan; 91(1):75-80. PubMed ID: 7034261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extraintestinal pathogenic Escherichia coli survives within neutrophils.
    Nazareth H; Genagon SA; Russo TA
    Infect Immun; 2007 Jun; 75(6):2776-85. PubMed ID: 17296761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synergy of simultaneous administration of ofloxacin and granulocyte colony-stimulating factor in killing of Escherichia coli by human neutrophils.
    Kropec A; Lemmen SW; Grundmann HJ; Engels I; Daschner FD
    Infection; 1995; 23(5):298-300. PubMed ID: 8557389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intracellular survival of virulent Bordetella pertussis in human polymorphonuclear leukocytes.
    Steed LL; Setareh M; Friedman RL
    J Leukoc Biol; 1991 Oct; 50(4):321-30. PubMed ID: 1919361
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Influrence of recombinant human procalcitonin on phagocytic and candidacidal ability of polymorphonuclear leukocytes and on killing mechanisms of serum and blood aganist bacteria Staphylococcus aureus and Escherichia coli].
    Pincíková T; Bucová M; Slobodníková L
    Vnitr Lek; 2005 Dec; 51(12):1365-70. PubMed ID: 16430103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Strains of Escherichia coli associated with urogenital disease in dogs and cats.
    Wilson RA; Keefe TJ; Davis MA; Browning MT; Ondrusek K
    Am J Vet Res; 1988 Jun; 49(6):743-6. PubMed ID: 3041880
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Virulence and other phenotypic characteristics of urinary isolates of cysteine-requiring Escherichia coli.
    McIver CJ; Tapsall JW
    J Med Microbiol; 1995 Jan; 42(1):39-42. PubMed ID: 7739023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Haemolytic Escherichia coli in etiopathogenesis of pyelonephritis in rats--an experimental study.
    Akulwar SL; Kurhade AM; Saoji AM
    Indian J Pathol Microbiol; 1997 Jan; 40(1):47-9. PubMed ID: 9145611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Environmental regulation of alpha-haemolysin expression in Escherichia coli.
    Mouriño M; Muñoa F; Balsalobre C; Diaz P; Madrid C; Juarez A
    Microb Pathog; 1994 Apr; 16(4):249-59. PubMed ID: 7968454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli.
    Mannion BA; Weiss J; Elsbach P
    J Clin Invest; 1990 Aug; 86(2):631-41. PubMed ID: 2200807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Escherichia coli K antigen in relation to serum-induced lysis and phagocytosis.
    Van Dijk WC; Verbrugh HA; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
    J Med Microbiol; 1979 Feb; 12(1):123-30. PubMed ID: 372531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.